Oragenics Inc (OGEN): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$127.5K
Year ended 2022-12-31
+71.7%
3-year compound annual growth
+27.7%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $127.5K | +190.6% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $43.9K | n/a | 2023-04-17, From 2021-01-01 |
| No annual figure between 2019-12-31 and 2021-12-31. | |||
| 2019-12-31 | $25.2K | -79.8% | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | $124.7K | n/a | 2020-03-04, From 2018-01-01 |
| No annual figure between 2016-12-31 and 2018-12-31. | |||
| 2016-12-31 | $27.2K | -73.5% | 2018-02-16, From 2016-01-01 |
| 2015-12-31 | $102.5K | -7.4% | 2017-02-27, From 2015-01-01 |
| 2014-12-31 | $110.7K | +488.4% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $18.8K | +69.5% | 2015-02-27, From 2013-01-01 |
| 2012-12-31 | $11.1K | n/a | 2014-02-28, From 2012-01-01 |
| No annual figure between 2010-12-31 and 2012-12-31. | |||
| 2010-12-31 | $88.1K | n/a | 2012-04-16, From 2010-01-01 |